Organization
Kagoshima University Hospital
3 abstracts
Abstract
A confirmatory trial of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumor diameter preoperatively estimated at 2 cm or less: Japan Clinical Oncology Group study, JCOG1101.Org: Toranomon Hospital, Tokyo Metropolitan Bokutoh Hospital, Radiation Therapy Center, Okinawa Chubu Hospital, Kagoshima University Hospital,
Abstract
Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan.Org: Mie University Graduate School of Medicine, Tsu, Japan, Shimane University Hospital, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Nagano Prefectural Shinshu Medical Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Final three-year follow-up analysis of phase I/II study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.Org: Department of Neurosurgery, Peking Union Medical College Hospital, Beijing, China, Osaka International Cancer Institute, Osaka, Japan, Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kyorin University Faculty of Medicine,